Other Species / Isoforms
  RPLP2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y3-p
_____MRyVAsyLLA
Upstream
0 20
Treatment
  • nocodazole
RPLP2 (human) _____MRyVAsyLLA Y3-p
RPLP2 (mouse) _____MRyVAsyLLA Y3-p
RPLP2 (rat) _____MRYVASYLLA Y3
S6-p
__MRyVAsyLLAALG
Upstream
0 4
Treatment
  • nocodazole
RPLP2 (human) __MRyVAsyLLAALG S6-p
RPLP2 (mouse) __MRyVAsyLLAALG S6-p
RPLP2 (rat) __MRYVASYLLAALG S6
Y7-p
_MRyVAsyLLAALGG
Upstream
0 4
Treatment
  • nocodazole
RPLP2 (human) _MRyVAsyLLAALGG Y7-p
RPLP2 (mouse) _MRyVAsyLLAALGG Y7-p
RPLP2 (rat) _MRYVASYLLAALGG Y7
S16-p
LAALGGNssPsAkDI
0 7
RPLP2 (human) LAALGGNssPsAkDI S16-p
RPLP2 (mouse) LAALGGNssPsAkDI S16-p
RPLP2 (rat) LAALGGNSNPSAkDI S16
S17-p
AALGGNssPsAkDIk
Upstream
0 47
Regulatory protein:
  • OGT (human)
Treatment
  • anti-CD3
  • nocodazole
RPLP2 (human) AALGGNssPsAkDIk S17-p
RPLP2 (mouse) AALGGNssPsAkDIk S17-p
RPLP2 (rat) AALGGNSNPSAkDIK N17
S19-p
LGGNssPsAkDIkkI
0 7
RPLP2 (human) LGGNssPsAkDIkkI S19-p
RPLP2 (mouse) LGGNssPsAkDIkkI S19-p
RPLP2 (rat) LGGNSNPSAkDIKkI S19
K21-ac
GNssPsAkDIkkILD
0 14
RPLP2 (human) GNssPsAkDIkkILD K21-ac
RPLP2 (mouse) GNssPsAkDIkkILD K21-ac
RPLP2 (rat) GNSNPSAkDIKkILD K21-ac
K21-ub
GNssPsAkDIkkILD
Upstream
0 102
Treatment
  • MG132
RPLP2 (human) GNssPsAkDIkkILD K21-ub
RPLP2 (mouse) GNssPsAkDIkkILD K21-ub
RPLP2 (rat) GNSNPSAKDIKkILD K21
K21-sc
GNssPsAkDIkkILD
0 1
RPLP2 (human) GNssPsAkDIkkILD K21-sc
RPLP2 (mouse) GNssPsAKDIkkILD K21
RPLP2 (rat) GNSNPSAKDIKkILD K21
K24-ub
sPsAkDIkkILDsVG
0 33
RPLP2 (human) sPsAkDIkkILDsVG K24-ub
RPLP2 (mouse) sPsAkDIkkILDSVG K24-ub
RPLP2 (rat) NPSAkDIKkILDSVG K24
K25-ac
PsAkDIkkILDsVGI
0 3
RPLP2 (human) PsAkDIkkILDsVGI K25-ac
RPLP2 (mouse) PsAkDIkKILDSVGI K25
RPLP2 (rat) PSAkDIKkILDSVGI K25-ac
K25-ub
PsAkDIkkILDsVGI
0 27
RPLP2 (human) PsAkDIkkILDsVGI K25-ub
RPLP2 (mouse) PsAkDIkkILDSVGI K25-ub
RPLP2 (rat) PSAkDIKKILDSVGI K25
S29-p
DIkkILDsVGIEADD
0 3
RPLP2 (human) DIkkILDsVGIEADD S29-p
RPLP2 (mouse) DIkkILDSVGIEADD S29
RPLP2 (rat) DIKkILDSVGIEADD S29
K41
ADDDRLNKVISELNG
0 1
RPLP2 (human) ADDDRLNKVISELNG K41
RPLP2 (mouse) ADDDRLNKVISELNG K41
RPLP2 (rat) ADDERLNkVISELNG K41-ac
K41-ub
ADDDRLNkVISELNG
0 49
RPLP2 (human) ADDDRLNkVISELNG K41-ub
RPLP2 (mouse) ADDDRLNkVISELNG K41-ub
RPLP2 (rat) ADDERLNKVISELNG K41
K41-sm
ADDDRLNkVISELNG
0 1
RPLP2 (human) ADDDRLNkVISELNG K41-sm
RPLP2 (mouse) ADDDRLNKVISELNG K41
RPLP2 (rat) ADDERLNKVISELNG K41
K41-m1
ADDDRLNkVISELNG
0 1
RPLP2 (human) ADDDRLNkVISELNG K41-m1
RPLP2 (mouse) ADDDRLNKVISELNG K41
RPLP2 (rat) ADDERLNKVISELNG K41
K49-ac
VISELNGkNIEDVIA
0 5
RPLP2 (human) VISELNGkNIEDVIA K49-ac
RPLP2 (mouse) VISELNGKNIEDVIA K49
RPLP2 (rat) VISELNGkNIEDVIA K49-ac
K49-ub
VISELNGkNIEDVIA
0 75
RPLP2 (human) VISELNGkNIEDVIA K49-ub
RPLP2 (mouse) VISELNGkNIEDVIA K49-ub
RPLP2 (rat) VISELNGKNIEDVIA K49
K49-sc
VISELNGkNIEDVIA
0 1
RPLP2 (human) VISELNGkNIEDVIA K49-sc
RPLP2 (mouse) VISELNGKNIEDVIA K49
RPLP2 (rat) VISELNGKNIEDVIA K49
K61-ac
VIAQGIGkLAsVPAG
0 4
RPLP2 (human) VIAQGIGkLAsVPAG K61-ac
RPLP2 (mouse) VIAQGVGKLAsVPAG K61
RPLP2 (rat) VIAQGVGkLASVPAG K61-ac
K61-ub
VIAQGIGkLAsVPAG
0 16
RPLP2 (human) VIAQGIGkLAsVPAG K61-ub
RPLP2 (mouse) VIAQGVGkLAsVPAG K61-ub
RPLP2 (rat) VIAQGVGKLASVPAG K61
S64-p
QGIGkLAsVPAGGAV
0 19
RPLP2 (human) QGIGkLAsVPAGGAV S64-p
RPLP2 (mouse) QGVGkLAsVPAGGAV S64-p
RPLP2 (rat) QGVGkLASVPAGGAV S64
S74-p
AGGAVAVsAAPGsAA
0 9
RPLP2 (human) AGGAVAVsAAPGsAA S74-p
RPLP2 (mouse) AGGAVAVsAAPGsAA S74-p
RPLP2 (rat) AGGAVAVSAAPGsAA S74
S74
AGGAVAVSAAPGsAA
0 1
RPLP2 (human) AGGAVAVSAAPGsAA S74
RPLP2 (mouse) AGGAVAVsAAPGsAA S74-gl
RPLP2 (rat) AGGAVAVSAAPGsAA S74
S79-p
AVsAAPGsAAPAAGs
Upstream
0 36
Treatment
  • nocodazole
RPLP2 (human) AVsAAPGsAAPAAGs S79-p
RPLP2 (mouse) AVsAAPGsAAPAAGs S79-p
RPLP2 (rat) AVSAAPGsAAPAAGs S79-p
S86-p
sAAPAAGsAPAAAEE
0 32
RPLP2 (human) sAAPAAGsAPAAAEE S86-p
RPLP2 (mouse) sAAPAAGsAPAAAEE S86-p
RPLP2 (rat) sAAPAAGsAPAAAEE S86-p
K94-ub
APAAAEEkkDEkKEE
0 6
RPLP2 (human) APAAAEEkkDEkKEE K94-ub
RPLP2 (mouse) APAAAEEKKDEkKEE K94
RPLP2 (rat) APAAAEEKKDEKKEE K94
K95-ub
PAAAEEkkDEkKEEs
0 3
RPLP2 (human) PAAAEEkkDEkKEEs K95-ub
RPLP2 (mouse) PAAAEEKKDEkKEEs K95
RPLP2 (rat) PAAAEEKKDEKKEEs K95
K98-ub
AEEkkDEkKEEsEEs
0 3
RPLP2 (human) AEEkkDEkKEEsEEs K98-ub
RPLP2 (mouse) AEEKKDEkKEEsEEs K98-ub
RPLP2 (rat) AEEKKDEKKEEsEEs K98
S102-p
kDEkKEEsEEsDDDM
Upstream
3 460
Regulatory protein:
  • PRP4 (human)
Treatment
  • ischemia
  • LY294002
  • TNF
RPLP2 (human) kDEkKEEsEEsDDDM S102-p
RPLP2 (mouse) KDEkKEEsEEsDDDM S102-p
RPLP2 (rat) KDEKKEEsEEsDDDM S102-p
S105-p
kKEEsEEsDDDMGFG
Upstream
3 473
Regulatory protein:
  • TBK1 (human)
Treatment
  • lapatinib
  • LY294002
  • TNF
RPLP2 (human) kKEEsEEsDDDMGFG S105-p
RPLP2 (mouse) kKEEsEEsDDDMGFG S105-p
RPLP2 (rat) KKEEsEEsDDDMGFG S105-p